These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 9253329

  • 1. Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man.
    Berneis K, Ninnis R, Girard J, Frey BM, Keller U.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2528-34. PubMed ID: 9253329
    [Abstract] [Full Text] [Related]

  • 2. Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans.
    Oehri M, Ninnis R, Girard J, Frey FJ, Keller U.
    Am J Physiol; 1996 Apr; 270(4 Pt 1):E552-8. PubMed ID: 8928758
    [Abstract] [Full Text] [Related]

  • 3. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
    Lucidi P, Lauteri M, Laureti S, Celleno R, Santoni S, Volpi E, Angeletti G, Santeusanio F, De Feo P.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.
    Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB, Umpleby AM.
    J Clin Endocrinol Metab; 2004 Jan; 89(1):425-32. PubMed ID: 14715881
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
    Laager R, Ninnis R, Keller U.
    J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
    [Abstract] [Full Text] [Related]

  • 6. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism.
    Murphy MG, Plunkett LM, Gertz BJ, He W, Wittreich J, Polvino WM, Clemmons DR.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):320-5. PubMed ID: 9467534
    [Abstract] [Full Text] [Related]

  • 7. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
    Dall R, Longobardi S, Ehrnborg C, Keay N, Rosén T, Jørgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, Christiansen JS, Bengtsson BA, Sacca L, Baxter RC, Basset EE, Sönksen PH.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
    [Abstract] [Full Text] [Related]

  • 8. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
    Garrel DR, Moussali R, De Oliveira A, Lesiège D, Larivière F.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
    [Abstract] [Full Text] [Related]

  • 9. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

  • 11. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
    Mauras N, Horber FF, Haymond MW.
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor-I but not growth hormone attenuates dexamethasone-induced catabolism in parenterally fed rats.
    Lo HC, Hinton PS, Yang H, Unterman TG, Ney DM.
    JPEN J Parenter Enteral Nutr; 1996 Nov; 20(3):171-7. PubMed ID: 8776688
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.
    Bianda TL, Hussain MA, Keller A, Glatz Y, Schmitz O, Christiansen JS, Alberti KG, Froesch ER.
    Diabetologia; 1996 Aug; 39(8):961-9. PubMed ID: 8858219
    [Abstract] [Full Text] [Related]

  • 14. Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.
    Skjaerbaek C, Frystyk J, Møller J, Christiansen JS, Orskov H.
    Eur J Endocrinol; 1996 Dec; 135(6):672-7. PubMed ID: 9025711
    [Abstract] [Full Text] [Related]

  • 15. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.
    Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191
    [Abstract] [Full Text] [Related]

  • 16. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition.
    Vahl N, Møller N, Lauritzen T, Christiansen JS, Jørgensen JO.
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3612-8. PubMed ID: 9360515
    [Abstract] [Full Text] [Related]

  • 17. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
    Clemmons DR, Smith-Banks A, Underwood LE.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
    [Abstract] [Full Text] [Related]

  • 18. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
    Böni-Schnetzler M, Hauri C, Zapf J.
    Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
    [Abstract] [Full Text] [Related]

  • 19. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats.
    Grøfte T, Wolthers T, Jensen SA, Møller N, Jørgensen JO, Tygstrup N, Orskov H, Vilstrup H.
    Hepatology; 1997 Apr; 25(4):964-9. PubMed ID: 9096605
    [Abstract] [Full Text] [Related]

  • 20. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
    Damjanovic SS, Lalic NM, Pesko PM, Petakov MS, Jotic A, Miljic D, Lalic KS, Lukic L, Djurovic M, Djukic VB.
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.